20Med Therapeutics appoints Allard Kaptein to Supervisory Board
RELEASED ON OCTOBER 28, 2019. ENSCHEDE, The Netherlands, Oc. 28, 2019 – 20Med Therapeutics BV, a biotechnology company developing innovative nanoparticles for delivery of RNA therapeutics today announced the appointment of Dutch biotech veteran and serial ent...Read More
20Med Therapeutics and Partners Receive Eurostars Grant for the Development of New mRNA Therapeutics for Osteoarthritis
RELEASED ON JULY 24, 2019. 20Med Therapeutics today announced with its partners Ethris GmbH, the AO Research Institute Davos and Paracelsus Medical University the receipt of a Eurostars grant to be used to further the development of a novel approach to treatin...Read More
20Med Therapeutics secures new financing for accelerated development of the 20Med Nanogel technology for the delivery of RNA therapeutics
RELEASED ON NOVEMBER 2, 2017. Please find the document here...Read More
New Horizon 2020 Project B-SMART Develops RNA-based Therapy for Neurodegenerative Diseases.
RELEASED ON FEBRUARY 1, 2017 Pleas find the document here....Read More